You are here

Pfizer’s Competitive Grants Program

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an external review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP.

For all Investigator Sponsored Research (ISRs) and general research grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements. Pfizer must not be involved in any aspect of study protocol or project development, nor the conduct or monitoring of the research/quality improvement program.

Open RFPs

ADVANCE Global Awards for Advancing Chronic Pain Research

2019 Acromegaly ASPIRE Program (United States)

Hemophilia ASPIRE 2019 (Global)

2019 Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research Competitive Grant Program for Junior Investigators (Global)

2019 Transthyretin Amyloid Polyneuropathy (ATTR-PN) Research Competitive Grant Program for Junior Investigators (Global)

Transthyretin Cardiac Amyloidosis Fellowship

Carbapenem-Resistant Enterobacteriaceae (CRE) Surveillance in Africa and the Middle East

Improving Duration of Therapy and Outcomes in NSCLC Patients Receiving Targeted Therapy

2019 Inflammatory Bowel Disease Fellowship- International Competitive Grant Programme – Fellowship